成立了ADC开发和制造的合作伙伴关系. Partnership formed for ADC development and manufacturing.

皮拉马尔药物解决方案和阿吉诺莫托生物制剂服务公司已建立战略合作伙伴关系,以支持抗体-药物联合物的开发和生产. Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have formed a strategic partnership to support the development and manufacturing of antibody-drug conjugates. 这一合作将使两家公司能够相互推客户,同时转让技术以提高制造能力. The collaboration will allow the companies to refer customers to one another while also transferring technology to enhance manufacturing capabilities. 这一联盟旨在简化ADC的开发,并改善患者获得这些先进疗法的机会. This alliance aims to streamline ADC development and improve access to these advanced therapies for patients.